Show
Sort by
-
- Journal Article
- A1
- open access
Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores
-
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers
-
Height and body mass index as modifiers of breast cancer risk in BRCA1/2 mutation carriers : a Mendelian randomization study
-
- Journal Article
- A1
- open access
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
-
Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores
-
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
-
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
-
- Journal Article
- A1
- open access
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
-
- Journal Article
- A1
- open access
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction